NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00005951 Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005816 Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer Status COMPLETED Phase PHASE1
NCT00005081 Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma Status COMPLETED Phase PHASE2
NCT00004832 Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome Status COMPLETED Phase NA
NCT00004604 Biological Therapy in Treating Patients With Metastatic Cancer Status COMPLETED Phase PHASE1
NCT00004285 Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis Status COMPLETED Phase NA
NCT00004211 Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00003478 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00003467 Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma Status COMPLETED Phase PHASE2
NCT00003466 Temozolomide in Treating Patients With Progressive Low-Grade Glioma Status COMPLETED Phase PHASE2
NCT00003465 Temozolomide in Treating Patients With Anaplastic Oligodendroglioma Status COMPLETED Phase PHASE2
NCT00003464 Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme Status COMPLETED Phase PHASE2
NCT00003463 Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas Status COMPLETED Phase PHASE1
NCT00003462 Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors Status COMPLETED Phase PHASE1